Page last updated: 2024-10-26

donepezil and Ambulation Difficulty

donepezil has been researched along with Ambulation Difficulty in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research Excerpts

ExcerptRelevanceReference
"Donepezil is a commonly prescribed cholinesterase inhibitor in Alzheimer's dementia."1.48Acute inability to mobilise resulting from probable donepezil-induced myoclonus. ( Henderson, EJ; Huffman, AJ; Whateley, JM, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whateley, JM1
Huffman, AJ1
Henderson, EJ1

Other Studies

1 other study available for donepezil and Ambulation Difficulty

ArticleYear
Acute inability to mobilise resulting from probable donepezil-induced myoclonus.
    Age and ageing, 2018, 11-01, Volume: 47, Issue:6

    Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Mobility

2018